The general surgery devices market covers wide-ranging devices used in diagnostic and surgical procedures primarily for the gastrointestinal tract, abdomen, and pelvis. Reconstruction Meshes are surgically implantable woven sheets that are used to repair or support organs and other tissues. GlobalData uses proprietary data and analytics to provide a comprehensive report on the reconstruction meshes devices market, including market shares of different players within Taiwan. Buy the latest report here.
Smarter leaders trust GlobalData
In 2021, GlobalData’s Market Model methodology determined that the leading player in the reconstruction meshes market in Taiwan was Allergan Aesthetics followed by Ethicon, Integra LifeSciences, CR Bard, Coloplast, MTF Biologics, W. L. Gore & Associates, Baxter International and Boston Scientific.
The meshes are made either from synthetic material and/or bioengineered from animal tissues. Reconstruction meshes are generally available in multiple sizes, thicknesses, and pore sizes, however for this category the meshes are segmented based on the materials used to make them. They include Synthetic Mesh, Biologic Mesh, and Hybrid Mesh. Reconstruction meshes specifically indicated for hernia repair were excluded from this category, the data for which are presented in GlobalData’s Hernia Repair Devices category.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the reconstruction meshes devices market within Taiwan was expected to be over $40m in 2021.
For the latest complete market share analysis of reconstruction meshes device market in Taiwan, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
